Simplification of antiretroviral treatment will improve the quality of life of HIV patients

by Fundació Clínic per a la Recerca Biomèdica

3 years ago
Research, Treatment, HIV/AIDS, Infectious Diseases

A trial carried out entirely in Catalonia has shown that therapy with dolutegravir plus lamivudine has an efficacy similar to that of triple therapy. It does not cause resistance or have any side effe...

An IrsiCaixa project to diagnose and monitor infectious diseases, among the selected projects by the CaixaResearch Validate 2021 call

by IrsiCaixa

3 years ago
diagnostic, infectious diseases, monitor

'la Caixa' Foundation will provide €100,000 to the IrsiCaixa project, which aims to establish a diagnostic tool to better identify infections caused by HIV, SARS-CoV-2 and Mycobacterium tuberculosis...

Eight CSIC biomedical projects receive 6.5 million euros from the CaixaResearch aid program

by CSIC - Centro Superior de Investigaciones Científicas

4 years ago
Health Research, CaixaResearch, neurological diseases, Cancer, infectious diseases, cardiovascular diseases

Eight researches led by or with the participation of scientists from the Spanish National Research Council (CSIC) have been selected by the “la Caixa” Foundation among the 30 projects of the Caixa...

Therapeutic HIV vaccine achieves an immune response that improves viral control when antiretroviral treatment is interrupted

by IrsiCaixa

4 years ago
antiretroviral treatment, Infectious Diseases, vaccine, HIV

The HTI vaccine of AELIX Therapeutics, a spin-off of HIVACAT, shows in a Phase I/IIa clinical trial that 40% of the participants who received the vaccine have better control of the virus when the trea...

IDIBELL researchers identify three clinical profiles of patients with COVID-19 with prognostic implications

by Hospital Universitari de Bellvitge

4 years ago
Covid19, Infectious Diseases, monitoring

A study published in The Lancet Infectious Diseases, in which Bellvitge University Hospital (HUB) and the Bellvitge Biomedical Research Institute (IDIBELL) have participated, has identified three phen...

Telum Therapeutics raises € 4.1 million in its first round, led by Invivo Ventures, together with the co-investment of Clave Capital and CDTI-Innvierte

by Telum Therapeutics

5 years ago
Telum, CDTI-Innvierte, Clave Capital, Invivo Ventures, infectious diseases, enzybiotics, technological platform, Escherichia coli

Telum Therapeutics (‘Telum’), an emerging biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages, called enzybiotics, has ...

Grifols announces collaboration with US Government for a treatment against Covid-19

by CataloniaBio

5 years ago
Grifols, plasma, covid-19, infectious diseases, FDA

Grifols, a CataloniaBio & HealthTech member, has entered into a formal collaboration with the Food and Drug Administration (FDA) and other public health agencies of United States to collect plas...

25 years studying the immune system

by IrsiCaixa

5 years ago
HIV, infectious diseases, biomedicine, immune system

The IrsiCaixa AIDS Research Institute celebrates its 25th anniversary as an international center of reference in the field of HIV and infectious diseases. The research at IrsiCaixa is now expanding to...

Wildlife in Catalonia carry enteric bacteria resistant to critically important antimicrobials used in human health

by Universitat Autònoma de Barcelona (UAB)

5 years ago
enteric bacteria, antimicrobials, urban wastewate, infectious diseases, hedgehogs

A study carried out by researchers from the UAB, the IRTA-CReSA and the Torreferrussa Wildlife Center detected a high prevalence of bacteria with genes resistant to antibiotics, particularly those use...

One child dies of pneumonia every 39 seconds

by ISGlobal - Instituto de Salud Global de Barcelona

5 years ago
child, pneumonia, virus, infectious diseases

Pneumonia – a preventable disease – kills more children than any other infection

Mathematicians calculate the number of immune cells needed to thwart HIV progress

by UPF - Universitat Pompeu Fabra

6 years ago
cells, HIV, infectious diseases, vaccinations

In the future, a model of this kind will enable scientists to carry out computer experiments for the development of vaccines and medicines for infectious diseases. The study, led by Russian researcher...